All Work

Chris Lange

Why Phio Pharma Stock Is More Than Doubling

Phio Pharmaceuticals shares more than doubled on Friday after the firm announced positive data from its cancer study at the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program.

Chris Lange · 6 years ago

How Zscaler Knocked It Out of the Park in Q3

Shares of cloud-based information security company Zscaler surged on Friday after it released better than expected fiscal third-quarter financial results.

Chris Lange · 6 years ago

Did Analysts Overshoot Costco Earnings?

Costco reported disappointing fiscal second-quarter financial results after the markets closed on Thursday, due in part to COVID-related costs.

Chris Lange · 6 years ago

What’s Holding Salesforce Back in Q1

Salesforce.com reported fiscal first-quarter financial results after markets closed Tuesday. The firm posted $0.70 in earnings per share (EPS) and $4.87 billion in revenue compared to consensus estimates that called for $0.69 in EPS…

Chris Lange · 6 years ago

Cannabis Short Interest Takes a Dive

The May 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased, and in one stock incredibly.

Chris Lange · 6 years ago

Why Mersana’s Cancer Study Is Huge

Mersana Therapeutics shares jumped on Wednesday after the company reported interim results from its early-stage cancer study.

Chris Lange · 6 years ago